WHO
REGULATORY UPDATE
1st Invitation to manufacturers of medicinal products for treatment of childhood cancer, to submit an Expression of Interest (EOI) for product evaluation to the WHO Prequalification Unit
Published: 10/6/2026Detected: 8/13/2026
Summary preview
Invites manufacturers to submit expressions of interest for WHO Prequalification evaluation of selected childhood cancer medicines, with a specific focus on enabling child-friendly formulations through priority target…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountoncology
pediatrics
#WHO prequalification
#expression of interest (EOI)
#paediatric formulations
#target product profiles (TPPs)
#childhood cancer
Official Source Document Source Verified
Access the original document directly from WHO.